Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training
NCT ID: NCT02156245
Last Updated: 2019-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
212 participants
INTERVENTIONAL
2013-09-16
2019-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure
NCT02046707
Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease
NCT06480656
Rehabilitation by Eccentric Exercise in Heart Failure Patients
NCT03716778
Effect of an Eccentric Exercise Program on Quality of Life and Function in People With Chronic Heart Failure.
NCT02223624
The 400m-walk-test for Stable Coronary Patients
NCT01904929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PHASE 1 :
30 healthy volunteers will be included to test tolerance to personalized exercise on an eccentric cycle ergometer.
PHASE 2 :
15 patients suffering from coronary artery disease (CAD) and 15 patients suffering from chronic obstructive pulmonary disease (COPD) will be included to test the same protocol.
PHASE 3 :
A total of 169 patients split into 2 parallel groups will be included: a group receiving conventional rehabilitation (group A) and the other group receiving eccentric exercise combined to conventional rehabilitation (group B).
Coronary patients: 93 patients will be included (62 patients in group A and 31 in group B).
COPD patients: 76 patients will be included (38 patients per group).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"Conventional" group
conventional rehabilitation program (including concentric cycle ergometer)
"Combined" group
cycling included into a conventional rehabilitation program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
conventional rehabilitation program (including concentric cycle ergometer)
cycling included into a conventional rehabilitation program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Healthy volunteers:
* Men or women aged between 40 and 75 years.
Patients with CAD:
* Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program.
* Left ventricular ejection fraction on echocardiography (Simpson methode) \> 45 %
Patients with Chronic obstructive pulmonary disease:
* Men or women aged between 40 and 75 years
* Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC \< 0.70 and FEV1 ≤ 60% of predicted value)
* Patient not on oxygen therapy (24h/24)
Exclusion Criteria
* Severe, obstructive cardiopathy
* Severe aortic valve stenosis,
* Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test
* Cardiac intracavitary thrombus,
* Severe pulmonary artery hypertension (PAHT systolic \>70mmHg),
* Recent history of venous thromboembolism (previous 3 months),
* Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test \< 24),
* Heart transplant,
* Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…).
* Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index \< 0.6) or orthopedic (degenerative or inflammatory rheumatism).
* Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.
40 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de BESANCON
Besançon, , France
CHU de DIJON
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CASILLAS DB 2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.